Project Grant HT94252410272
Award Date
4/1/24
Completion Date
3/31/27
Dollars Obligated
$520K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15213, USA
Similar Awards
This federal Project Grant award for $5,238,417.00, granted by the Department of Defense's Military Medical Research and Development program (CFDA 12.420), funds a multi-year research project titled "OPTIMIZING A SURVEILLANCE STRATEGY TO TACKLE BREAST CANCER DORMANCY AND MINIMAL RESIDUAL DISEASE". The award was made on Sep 15, 2023 to The Trustees Of The University Of Pennsylvania, with an ultimate completion date of Sep 14, 2027. A key sub-award was made to Trustees Of Indiana...
This federal Project Grant award of $3,333,240.00 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Allegheny Singer Research Institute (AHN Research Institute) to understand the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. The research aims to explore innovative approaches to the prevention, diagnosis, treatment, and management of...
This Defense Health Agency (DHA) Project Grant award for $4,509,475.00, granted on Sep 15, 2023 under the Military Medical Research and Development program (CFDA 12.420), supports a 4-year research project titled "Optimizing a Surveillance Strategy to Tackle Breast Cancer Dormancy and Minimal Residual Disease" to be conducted by the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The objective of this research is...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This $846,182 Project Grant award to the University of Pittsburgh was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project titled "INTRAGENIC REARRANGEMENT BURDEN AS A GENOMIC PREDICTOR OF IMMUNOTHERAPY BENEFIT IN TRIPLE-NEGATIVE BREAST CANCER" with a performance period from Aug 1, 2024 to Jul 31, 2027. As a major research university, the University of Pittsburgh will leverage its extensive...
This $1,305,270 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports the "Ovarian Cancer Academy: Advancing Ovarian Cancer Research through Mentorship, Networking, and Collaborations" initiative led by The Trustees of the University of Pennsylvania. The award aims to transform healthcare for military service members and the general public through innovative biomedical research in...
The University of Pittsburgh was awarded a $712,770 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research into the role of RUNX1 rearrangements in triple-negative breast cancer progression and immune evasion. Through September 2025, the University will investigate medical solutions for aggressive breast cancers that lack estrogen receptors, progesterone receptors, and excess HER2...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $346,319.00 to the University of Pittsburgh to conduct research on "INTRAGENIC REARRANGEMENT BURDEN AS A GENOMIC PREDICTOR OF IMMUNOTHERAPY BENEFIT IN TRIPLE-NEGATIVE BREAST CANCER." The award period runs from August 1, 2024 to July 31, 2027. The University of Pittsburgh, a major public research university, will leverage its expertise in...
The Johns Hopkins University received a three-year, $651,158 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support the university's research into early assessment of treatment response in breast cancer patients undergoing neoadjuvant therapy using an automated liquid biopsy-breast cancer methylation assay. The Military Medical Research and Development program aims to transform military...
This $838,911 Project Grant awarded by the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research by The Institute For Cancer Research to identify regulators of PALB2 function and PARP inhibitor resistance in triple-negative breast cancer. The 3-year award, beginning January 2024, will fund work to advance the understanding of genetic and molecular mechanisms underlying treatment resistance in this aggressive form of breast cancer. As a prime...